DERM logo

Journey Medical (DERM)

Profile

Full Name

Journey Medical Corporation

Ticker Symbol

DERM

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

November 12, 2021

Indexes

Not included

Website

http://journeymedicalcorp.com

Employees

41

Key Details

Price

$6.25(+0.64%)

Market cap

$144.40M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$56.13M(-29.11% YoY)

Annual EPS

-$0.72(-242.86% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.25
DERM price is $6.25

30-Day Relative Volume

0.64
DERM 30-day relative volume is 0.64

Price Performance

Price Most recent change

+0.64%
DERM price was up +0.64% on Apr 17, 2025

Price YTD change

+59.85%
DERM price is up +59.85% since January 1st

Price 1-year change

+61.92%
DERM price is up +61.92% year-on-year

Price 3-year change

+31.58%
DERM price is up +31.58% over the past 3 years

Price Range

Price All-time high

$10.20
DERM price is currently -38.73% below its historical high of $10.20

Price 3-year low

$1.02
DERM price is currently +512.75% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$144.40M
DERM market capitalization is $144.40 million

Market cap 3-year change

+75.54%
DERM market capitalization is up +75.54% over the past 3 years

Market cap All-time high

$166.12M
DERM market capitalization is currently -13.07% below its historical high of $166.12 million

Market cap sector rank

52.8%
DERM market capitalization is higher than 52.8% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+15.91%
DERM shares outstanding is up +15.91% year-on-year

Shares Outstanding 3-Year Change

+33.41%
DERM shares outstanding is up +33.41% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.65
DERM beta is 0.65

200-day SMA

$5.26
DERM price is currently +18.89% above its 200-day simple moving average

50-day SMA

$5.66
DERM price is currently +10.52% above its 50-day simple moving average

RSI

53.12
DERM 14-day relative strength index is 53.12

Volume

0.64
DERM 30-day relative volume is 0.64

ATR

$0.55
DERM average true range is $0.55

10-day Historical Volatility

100.35%
DERM 10-day historical volatility is 100.35%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$56.13M
DERM annual revenue is $56.13 million

Revenue Analysts estimate

$71.45M
DERM annual revenue is currently -21.44% lower than the consensus analysts' forecast

Revenue 1-year change

-29.11%
DERM annual revenue is down -29.11% year-on-year

Revenue Sector rank

48.38%
DERM annual revenue is higher than 48.38% of companies in Healthcare sector

EPS

EPS

-$0.72
DERM annual earnings per share is -$0.72

EPS Analysts estimate

-
DERM annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-242.86%
DERM annual earnings per share is down -242.86% year-on-year

EPS Sector rank

62.89%
DERM annual earnings per share is higher than 62.89% of companies in Healthcare sector

Profit

Gross profit

$35.26M
DERM annual gross profit is $35.26 million

Gross margin

62.81%
DERM annual gross profit margin is 62.81%

Operating profit

-$18.23M
DERM annual operating income is -$18.23 million

Operating margin

-32.48%
DERM annual operating profit margin is -32.48%

Net income

-$14.67M
DERM annual net profit is -$14.67 million

Net margin

-26.14%
DERM annual net profit margin is -26.14%

Expenses

Total expenses

$74.36M
DERM annual total expenses is $74.36 million

Operating expenses

$53.48M
DERM annual total operating expenses is $53.48 million

Cost of goods sold

$20.88M
DERM annual cost of goods sold is $20.88 million

Selling, general & administrative expenses

$40.20M
DERM annual SGA is $40.20 million

Depreciation and amortization

$3.52M
DERM annual depreciation & amortization is $3.52 million

Interest expense

$2.70M
DERM annual interest expense is $2.70 million

Income tax

$61.00K
DERM annual income tax is $61.00 thousand

EBIT & EBITDA

EBIT

-$11.91M
DERM annual earnings before interest & taxes is -$11.91 million

EBITDA

-$8.40M
DERM annual EBITDA is -$8.40 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$80.24M
DERM annual total assets is $80.24 million

Non current assets

$32.06M
DERM annual long term assets is $32.06 million

Current assets

$48.18M
DERM annual total current assets is $48.18 million

Cash and cash equivalents

$20.30M
DERM annual cash & cash equivalents is $20.30 million

Accounts receivable

$10.23M
DERM annual accounts receivable is $10.23 million

Inventory

$14.43M
DERM annual inventory is $14.43 million

Liabilities

Total liabilities

$60.17M
DERM annual total liabilities is $60.17 million

Long term liabilities

$25.00M
DERM annual total long term liabilities is $25.00 million

Current liabilities

$35.17M
DERM annual total current liabilities is $35.17 million

Accounts payable

$16.05M
DERM annual accounts payable is $16.05 million

Debt

Total debt

$25.08M
DERM annual total debt is $25.08 million

Total debt 1-year change

+70.26%
DERM annual total debt is up +70.26% year-on-year

Long term debt

$25.00M
DERM annual long term debt is $25.00 million

Short term debt

$83.00K
DERM annual short term debt is $83.00 thousand

Equity & Capital

Shareholders equity

$20.07M
DERM annual stockholders equity is $20.07 million

Book value

$20.07M
DERM annual book value is $20.07 million

Retained earnings

-$87.03M
DERM annual retained earnings is -$87.03 million

Working capital

$13.00M
DERM annual working capital is $13.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$9.13M
DERM annual cash flow from operations is -$9.13 million

Cash from operations 1-year change

-274.18%
DERM annual cash flow from operations is down -274.18% year-on-year

Cash from investing

-$15.00M
DERM annual cash flow from investing activities is -$15.00 million

Cash from investing 1-year change

-200%
DERM annual cash flow from investing activities is down -200% year-on-year

Cash from financing

$16.99M
DERM annual cash flow from financing activities is $16.99 million

Cash from financing 1-year change

+453.73%
DERM annual cash flow from financing activities is up +453.73% year-on-year

CAPEX

CAPEX

$15.00M
DERM annual capital expenditures is $15.00 million

CAPEX 1-year change

+200%
DERM annual capital expenditures is up +200% year-on-year

Free Cash Flow

Free cash flow

-$24.13M
DERM annual free cash flow is -$24.13 million

Free cash flow 1-year change

-10152.92%
DERM annual free cash flow is down -10152.92% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

62.81%
DERM annual gross profit margin is 62.81%

Operating margin

-32.48%
DERM annual operating profit margin is -32.48%

Net margin

-26.14%
DERM annual net profit margin is -26.14%

ROA & ROE

ROA

-18.68%
DERM annual return on assets is -18.68%

ROE

-72.60%
DERM annual return on equity is -72.60%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DERM price to earnings ratio value is unknown

PE ratio Sector rank

-
DERM price to earnings ratio is unknown

PB Ratio

PB ratio

7.20
DERM price to book ratio is 7.20

PB ratio Sector rank

89.04%
DERM price to book ratio is higher than 89.04% of companies in Healthcare sector

PS Ratio

PS ratio

2.57
DERM price to sales ratio is 2.57

PS ratio Sector rank

47.95%
DERM price to sales ratio is higher than 47.95% of companies in Healthcare sector

Enterprise value

Enterprise value

$149.18M
DERM enterprise value is $149.18 million

Enterprise value Sector rank

54.42%
DERM enterprise value is higher than 54.42% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-17.77
DERM EV/EBITDA is -17.77

EV/EBITDA Sector rank

6.78%
DERM EV/EBITDA is higher than 6.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.37
DERM annual current ratio is 1.37

Quick ratio

0.96
DERM annual quick ratio is 0.96

Leverage

Debt to equity

1.24
DERM annual debt to equity ratio is 1.24

Interest coverage ratio

-4.41
DERM annual interest coverage ratio is -4.41

Risk & Stability

Piotroski F-Score

2
DERM piotroski f-score is 2

Altman Z-Score

0.33
DERM altman z-score is 0.33

Analyst ratings

Recent major analysts updates

Feb 16, 24 Alliance Global Partners
Buy
Sep 7, 23 B. Riley Securities
Buy
Jul 12, 23 B. Riley Securities
Buy
May 23, 23 B. Riley Securities
Buy
Mar 30, 23 B. Riley Securities
Buy
Feb 25, 22 Cantor Fitzgerald
Overweight
Dec 16, 21 Roth Capital
Buy
Dec 7, 21 B. Riley Securities
Buy

Institutional Ownership

Similar stocks

CLLS logo
Cellectis SA (CLLS)
CATX logo
Perspective Therapeutics (CATX)
TARA logo
Protara Therapeutics (TARA)
PROF logo
Profound Medical (PROF)
MOLN logo
Molecular Partners AG (MOLN)
PBYI logo
Puma Biotechnology (PBYI)
FDMT logo
4D Molecular Therapeutics (FDMT)
ZJYL logo
Jin Medical International (ZJYL)
IKT logo
Inhibikase Therapeutics (IKT)
  • What is the ticker symbol for Journey Medical?
  • Does Journey Medical pay dividends?
  • What sector is Journey Medical in?
  • What industry is Journey Medical in?
  • What country is Journey Medical based in?
  • When did Journey Medical go public?
  • Is Journey Medical in the S&P 500?
  • Is Journey Medical in the NASDAQ 100?
  • Is Journey Medical in the Dow Jones?
  • When was Journey Medical's last earnings report?
  • When does Journey Medical report earnings?
  • Should I buy Journey Medical stock now?

What is the ticker symbol for Journey Medical?

The ticker symbol for Journey Medical is NASDAQ:DERM

Does Journey Medical pay dividends?

No, Journey Medical does not pay dividends

What sector is Journey Medical in?

Journey Medical is in the Healthcare sector

What industry is Journey Medical in?

Journey Medical is in the Drug Manufacturers - Specialty & Generic industry

What country is Journey Medical based in?

Journey Medical is headquartered in United States

When did Journey Medical go public?

Journey Medical's initial public offering (IPO) was on November 12, 2021

Is Journey Medical in the S&P 500?

No, Journey Medical is not included in the S&P 500 index

Is Journey Medical in the NASDAQ 100?

No, Journey Medical is not included in the NASDAQ 100 index

Is Journey Medical in the Dow Jones?

No, Journey Medical is not included in the Dow Jones index

When was Journey Medical's last earnings report?

Journey Medical's most recent earnings report was on Mar 26, 2025

When does Journey Medical report earnings?

The next expected earnings date for Journey Medical is May 13, 2025

Should I buy Journey Medical stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page